Table A 3.2.
Overall survival, mean (95% CrI) | |||||
---|---|---|---|---|---|
Historical trials
|
|||||
FFCD-8801 | NSAS-GC | JCOG-9206-1 | JCOG-8801 | SWOG-7804 | |
Observed | 0.84 (0.62, 1.14) | 0.51 (0.29, 0.90) | 0.60 (0.31, 1.18) | 0.82 (0.54, 1.27) | 0.93 (0.70, 1.24) |
Meta-regression | 0.87 (0.63, 1.19) | 0.50 (0.26, 0.97) | 0.65 (0.33, 1.25) | 0.82 (0.53, 1.26) | 0.91 (0.67, 1.24) |
BRMA | 0.86 (0.62, 1.19) | 0.86 (0.50, 1.47) | 0.85 (0.45, 1.62) | 0.85 (0.55, 1.32) | 0.86 (0.63, 1.17) |
EORTC-40813 | Tsavaris | ICCG-1/81 | ITMO | GITSG-8174 | |
| |||||
Observed | 0.85 (0.64, 1.14) | 0.55 (0.33, 0.89) | 0.85 (0.64, 1.13) | 0.98 (0.70, 1.37) | 0.74 (0.53, 1.04) |
Meta-regression | 0.78 (0.57, 1.06) | 0.58 (0.33, 1.02) | 0.91 (0.67, 1.24) | 0.93 (0.66, 1.31) | 0.76 (0.53, 1.09) |
BRMA | 0.84 (0.61, 1.14) | 0.85 (0.52, 1.40) | 0.87 (0.63, 1.19) | 0.86 (0.61, 1.20) | 0.85 (0.59, 1.21) |
NCTTG-794151 | ECCOG-EST3275 | EORTC-40905 | ICCG | ||
| |||||
Observed | 1.02 (0.69, 1.51) | 0.94 (0.68, 1.30) | 0.93 (0.64, 1.37) | 1.05 (0.74, 1.49) | |
Meta-regression | 0.99 (0.65, 1.49) | 0.93 (0.66, 1.31) | 0.92 (0.62, 1.36) | 1.11 (0.75, 1.66) | |
BRMA | 0.86 (0.57, 1.29) | 0.86 (0.61, 1.22) | 0.86 (0.57, 1.28) | 0.86 (0.60, 1.23) | |
| |||||
Validation trials
|
|||||
A-cirera | B-CLASSIC | E-GOIM-9602 | F-GOIRC | ||
| |||||
Observed | 0.60 (0.39, 0.93) | 0.72 (0.52, 1.00) | 0.91 (0.69, 1.21) | 0.90 (0.64, 1.26) | |
Meta-regression | 0.57 (0.35, 0.93) | 0.58 (0.41, 0.82) | 0.92 (0.68, 1.24) | 0.96 (0.67, 1.38) | |
BRMA | 0.82 (0.52, 1.27) | 0.79 (0.60, 1.05) | 0.86 (0.64, 1.17) | 0.87 (0.60, 1.25) |